TrialAnnals of surgery2004

Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Christian Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.